GAMMA Investing LLC Has $1.81 Million Stock Holdings in Select Medical Holdings Corporation (NYSE:SEM)

GAMMA Investing LLC lifted its position in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 5,201.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 108,567 shares of the health services provider's stock after purchasing an additional 106,519 shares during the period. GAMMA Investing LLC owned 0.08% of Select Medical worth $1,813,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of SEM. NorthCrest Asset Manangement LLC bought a new stake in shares of Select Medical during the 4th quarter worth about $209,000. Phocas Financial Corp. bought a new stake in shares of Select Medical during the 4th quarter worth about $1,877,000. Brucke Financial Inc. bought a new stake in shares of Select Medical during the 4th quarter worth about $245,000. Mackenzie Financial Corp boosted its holdings in shares of Select Medical by 726.3% during the 4th quarter. Mackenzie Financial Corp now owns 66,497 shares of the health services provider's stock worth $1,253,000 after buying an additional 58,449 shares during the period. Finally, Neo Ivy Capital Management boosted its holdings in shares of Select Medical by 342,890.0% during the 4th quarter. Neo Ivy Capital Management now owns 34,299 shares of the health services provider's stock worth $646,000 after buying an additional 34,289 shares during the period. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently commented on SEM shares. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a report on Monday, February 24th. Royal Bank Of Canada cut their price objective on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, May 7th. Wall Street Zen raised shares of Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Finally, Mizuho began coverage on shares of Select Medical in a report on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price objective for the company. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $26.00.

Insider Activity

In other news, Director Parvinderjit S. Khanuja bought 21,000 shares of the company's stock in a transaction dated Monday, May 5th. The stock was bought at an average cost of $15.02 per share, for a total transaction of $315,420.00. Following the transaction, the director now owns 65,089 shares of the company's stock, valued at $977,636.78. This represents a 47.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David S. Chernow sold 225,000 shares of the company's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the transaction, the chief executive officer now owns 714,516 shares of the company's stock, valued at approximately $12,861,288. This represents a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.60% of the company's stock.

Select Medical Stock Performance

NYSE SEM traded up $0.21 during trading on Wednesday, reaching $14.94. The company's stock had a trading volume of 1,684,452 shares, compared to its average volume of 965,455. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.87. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 11.15, a price-to-earnings-growth ratio of 0.78 and a beta of 1.34. Select Medical Holdings Corporation has a 12 month low of $14.03 and a 12 month high of $40.98. The firm has a 50 day moving average price of $15.59 and a 200 day moving average price of $17.48.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The business's revenue for the quarter was down 24.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.75 EPS. As a group, equities analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th were given a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.67%. The ex-dividend date of this dividend was Thursday, May 15th. Select Medical's payout ratio is presently 18.66%.

Select Medical declared that its board has initiated a share buyback program on Thursday, May 1st that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its shares are undervalued.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.